CMS issued guidance signaling tighter oversight of budget neutrality for Medicaid section 1115 demonstrations. The move centers on constraining how demonstration spending is measured and justified, with direct consequences for both federal and state Medicaid costs. This is a meaningful cost development because it could limit financing flexibility that states have used to support higher spending under waiver authority.
